Thus, this might suggest that N-cadherin expression contributes to the acquisition of mesenchymal phenotype in SCC when compared with BCC, with a high expression of E-cadherin in both tumors explaining their overall low metastatic potential. The gene discussed is CDH2; the disease is skin basal cell carcinoma.